Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Stone who wrote (4276)	10/19/1999 7:29:00 PM
From: John H. Farro	Read Replies (1) \| Respond to of 4342

Hi Rick and Larry, It seems like forever since I've seen you two on this board! Welcome back. Paracelsian has four major programs going. I am not sure what, if any progress has been made with their drug discovery program. I'm not sure if you know this, Rick, but AndroCar did not work when they tested it on mice. That doesn't necessarily mean it will never work. Last I heard they were trying to figure out why it didn't work. If they can figure this out they may be able to tweak the AndroCar molecule to overcome this difficulty. I don't know if they have made real progress in this program or not. We are still waiting on news from the BioFIT program. Check out PRLN's home page to learn what this is about. They had signed a deal with R.P. Scherer and I was hoping that we would be seeing more by now. We were hoping to have BioFIT products on the shelves this fall. Well, maybe it is still possible since fall is less than half over, but this is still up in the air. Maybe R.P.Scherrer should keep its initials and change its name to Realy Painfully Slow. They are making good progress on their web sites. The China-Med site is truly impressive and I think this could end up being a big winner. They probably chose the name "YourHealthPortal.com" because "YourHealth.com" was already taken. And remember the how that pathetic excuse for a former CEO cried big crocodile tears about how big bad Dow had tricked us out of the right to use our Ah-ImmunoAssay? Well, now we have a management team that is doing something with it. They have deals in Japan and Europe that will help us distribute our test kits. You should check out the web site and read some of the press releases. This is still a risky stock. Revenues are picking up but they are still not flush with cash and they are not at breakeven yet. It looks like we are firing on at least two of four cylindars. If we get some positive news on the BioFIT front then that could really lift the stock. I think there is a reassonable possibility that this will happen, but your guess is good as mine. If we get good news on the drug discovery front then that could boost this to the moon--but don't hold your breath on this one. I suspect that it may take a while for news to happen here. I'm still in this pretty heavlily. I can't say I am happy with the stock price but I think there is still a reasonably good chance that it could turn around. This is still risky and it might not work out, but I am convinced that this management, unlike previous management, is trying to do everything it can to make this company successful. Robin It's good to have the gang back. I wonder what happened to Paul and Judy?